Li-kun Chen
- Co-authors
- Yin-duo ZengHai LiaoFei XuLi ZhangXue HouWei-Dong WeiYing LiangYan Huang
- Topics
- Lung Cancer Research Studies (9 papers)Lung Cancer Treatments and Mutations (8 papers)Brain Metastases and Treatment (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Li-kun Chen
17 papers receiving 404 citations
Peers
Comparison fields: 5 of 57
- Oncology 279
- Pulmonary and Respiratory Medicine 247
- Molecular Biology 85
- Genetics 41
- Pharmacology 20
Countries citing papers authored by Li-kun Chen
This map shows the geographic impact of Li-kun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-kun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-kun Chen more than expected).
Fields of papers citing papers by Li-kun Chen
This network shows the impact of papers produced by Li-kun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-kun Chen. The network helps show where Li-kun Chen may publish in the future.
Co-authorship network of co-authors of Li-kun Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Li-kun Chen. A scholar is included among the top collaborators of Li-kun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li-kun Chen. Li-kun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 15 | |
| 6 | 26 | |
| 7 | 93 | |
| 8 | 16 | |
| 9 | 27 | |
| 10 | 1 | |
| 11 | 50 | |
| 12 | 66 | |
| 13 | 30 | |
| 14 | 13 | |
| 15 | 7 | |
| 16 | 7 | |
| 17 | 45 |
About Li-kun Chen
Li-kun Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 17 papers that have together received 408 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Brain Metastases and Treatment (6 papers). The work is most often cited by research in Oncology (279 citations), Pulmonary and Respiratory Medicine (247 citations) and Toxicology (14 citations). Li-kun Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yin-duo Zeng, Hai Liao, Fei Xu, Li Zhang, Xue Hou, Wei-Dong Wei, Ying Liang, Yan Huang, Junling Liu and Zhe‐Sheng Chen. Their work appears in journals such as Biochemical Pharmacology, European Journal of Pharmacology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.